Sunday - July 13, 2025
GSK data at ASCO and EHA showcase latest research and innovation across the oncology portfolio
May 29, 2025
LONDON, England, May 29 [Category: BizPharmaceuticals] -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK data at ASCO and EHA showcase latest research and innovation across the oncology portfolio

* Latest data on belantamab mafodotin combinations underscore the potential to transform treatment of 2L+ multiple myeloma

* New analyses from MOMENTUM and SIMPLIFY-1 trials at EHA emphasise . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products